Holen Sie sich die Stockscreener-App
1.18
0.00%
0.00
Schlusskurs vom Vortag:
$1.18
Offen:
$1.17
24-Stunden-Volumen:
51,031
Relative Volume:
0.27
Marktkapitalisierung:
$18.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.90M
KGV:
-0.00573
EPS:
-206.0125
Netto-Cashflow:
$-12.75M
1W Leistung:
+0.85%
1M Leistung:
+10.28%
6M Leistung:
+18.00%
1J Leistung:
+14.56%
1-Tages-Spanne:
$1.13
$1.20
1-Wochen-Bereich:
$1.09
$1.2282
52-Wochen-Spanne:
$0.6138
$2.35
Allarity Therapeutics Inc Stock (ALLR) Company Profile
Firmenname
Allarity Therapeutics Inc
Sektor
Branche
Telefon
401-426-4664
Adresse
24 SCHOOL ST., 2ND FLOOR, BOSTON
Vergleichen Sie ALLR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALLR
Allarity Therapeutics Inc
|
1.18 | 18.95M | 0 | -11.90M | -12.75M | -206.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Eingeleitet | Ascendiant Capital Markets | Buy |
Allarity Therapeutics Inc Aktie (ALLR) Neueste Nachrichten
Aug EndMonth: Is Allarity Therapeutics Inc backed by strong institutional buying2025 Analyst Calls & Risk Managed Investment Entry Signals - baoquankhu1.vn
Can Allarity Therapeutics Inc expand its profit margins2025 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Published on: 2026-01-16 08:05:07 - baoquankhu1.vn
Meme Stocks: Is Yuanbao Inc Depositary Receipt stock influenced by commodity pricesJuly 2025 Gainers & Reliable Price Action Trade Plans - baoquankhu1.vn
Market Outlook: What valuation multiples suggest for Allarity Therapeutics Inc stockJuly 2025 WrapUp & Weekly Stock Breakout Alerts - Bộ Nội Vụ
EV Market: Can Allarity Therapeutics Inc keep up with sector leadersProfit Target & Weekly Return Optimization Alerts - baoquankhu1.vn
Loss Report: Can Allarity Therapeutics Inc stock maintain growth trajectoryShare Buyback & Stepwise Trade Execution Plans - Bộ Nội Vụ
Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Cardio Diagnostics (NASDAQ:CDIO) - Defense World
Market Wrap: What dividend safety score for Allarity Therapeutics Inc stockQuarterly Performance Summary & Technical Confirmation Alerts - Bộ Nội Vụ
What catalysts could drive Allarity Therapeutics Inc. stock higherJuly 2025 Weekly Recap & Weekly High Momentum Picks - Улправда
Allarity Therapeutics, Inc.Common stock (NQ: ALLR - FinancialContent
How Allarity Therapeutics Inc. stock benefits from tech adoptionMarket Risk Report & Growth Oriented Trade Recommendations - Улправда
How strong is Allarity Therapeutics Inc. stock balance sheetPrice Support Zones & Free Tap Rapid Wealth - Улправда
News | postregister.comAllarity Therapeutics, Inc.Common stock (Nasdaq:ALLR) Price Chart - FinancialContent
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus
Is Allarity Therapeutics Inc. stock a buy before product launches2026 world cup usa national team qualification young talents high defensive line winner prediction guide - ulpravda.ru
Allarity CEO says 2026 represents an ‘inflection point’ - Yahoo Finance
Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders - GlobeNewswire
Cancer drug progress, cash runway updates in Allarity's year-end CEO letter - Stock Titan
Allarity Therapeutics, Inc. (NASDAQ:ALLR) Short Interest Down 21.9% in December - Defense World
Allarity Therapeutics Completes Additional Private Equity Financing - TipRanks
ALLR DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – ALLR - Macau Business
How Allarity Therapeutics Inc. stock reacts to Fed rate cutsEarnings Overview Summary & Smart Investment Allocation Tips - Улправда
Is Allarity Therapeutics Inc. stock oversold or undervalued2025 Stock Rankings & Smart Allocation Stock Tips - Улправда
Hedge Fund Bets: How Allarity Therapeutics Inc. stock reacts to Fed rate cuts2025 Major Catalysts & AI Optimized Trading Strategy Guides - Улправда
Will Allarity Therapeutics Inc. stock maintain dividend yieldJuly 2025 Final Week & High Conviction Investment Ideas - DonanımHaber
Is Allarity Therapeutics Inc. stock a bargain at current levels2025 Sector Review & Verified Stock Trade Ideas - Улправда
Published on: 2025-12-19 05:31:28 - Улправда
Allarity Therapeutics Earnings Notes - Trefis
Allarity Therapeutics Secures $2.5M Through Private Placement - MSN
Ascendiant Capital Maintains Allarity Therapeutics (ALLR) Buy Recommendation - Nasdaq
ALLR: Ascendiant Capital Raises Price Target, Maintains Buy Rati - GuruFocus
Allarity Therapeutics updates CFO employment agreement with full-time terms By Investing.com - Investing.com Australia
Allarity Therapeutics Appoints Jeffrey Ervin as Full-Time CFO - TipRanks
Allarity Therapeutics updates CFO employment agreement with full-time terms - Investing.com
Will Allarity Therapeutics Inc. stock benefit from sector rotationTrade Exit Summary & Trade Opportunity Analysis - Newser
Will Allarity Therapeutics Inc. stock return to pre crisis levelsPortfolio Update Report & High Yield Stock Recommendations - Newser
Can Allarity Therapeutics Inc. stock continue upward trendJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Allarity Therapeutics Inc to offer up to $50 million in securities - marketscreener.com
How Allarity Therapeutics Inc. stock trades before earningsJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - BỘ NỘI VỤ
Published on: 2025-11-28 11:27:30 - Bộ Nội Vụ
A new trading data show Allarity Therapeutics Inc (ALLR) is showing positive returns. - Setenews
Allarity Therapeutics Inc. (ALLR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Metastatic Breast Cancer Pipeline Insights Report 2025: Uncovering Breakthrough Drug Candidates Driving Future Market Growth - The Globe and Mail
Allarity Therapeutics, Inc. (ALLR) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is it too late to sell Allarity Therapeutics Inc.July 2025 Movers & High Yield Equity Trading Tips - newser.com
How Allarity Therapeutics Inc. stock performs in weak economyShare Buyback & Verified Momentum Stock Watchlist - newser.com
Will Allarity Therapeutics Inc. stock continue upward momentumJuly 2025 Decliners & Daily Stock Trend Reports - newser.com
Why Allarity Therapeutics Inc. stock appeals to analystsPortfolio Performance Report & Technical Pattern Based Signals - newser.com
Why retail investors pile into Allarity Therapeutics Inc. stockWeekly Loss Report & Verified Momentum Stock Ideas - newser.com
How Allarity Therapeutics Inc. stock reacts to oil pricesWeekly Trading Summary & High Accuracy Trade Alerts - newser.com
Finanzdaten der Allarity Therapeutics Inc-Aktie (ALLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.73%
0.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):